Related Experiment Videos
Carcinoma of the endometrium and hormonal receptors
Cancer Treatment and Research
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reproducibility of the histopathological classification of vulvar squamous carcinoma and intraepithelial neoplasia.
Journal of lower genital tract disease·2015
Human leukocyte antigen class I and II haplotypes and risk of cervical cancer.
Tissue antigens·2005
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Hormonal treatment of endometrial cancer: past, present and future.
Best practice & research. Clinical obstetrics & gynaecology·2001
Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States).
Cancer causes & control : CCC·2001
Role of androgens in the growth of endometrial carcinoma: an in vivo animal model.
American journal of obstetrics and gynecology·2001
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Lymphatic vascular aging and age-related bone loss: current status and future perspectives.
Frontiers in immunology·2026
Microbiota-driven metabolic-immune crosstalk in breast cancer.
Frontiers in pharmacology·2026